Physician profile
Luis E Rivera-Ramirez
NPI 1912969312
$2,842.73
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $417 · 2021: $479 · 2022: $758 · 2023: $539 · 2024: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $985.39 | 2019-2024 | Mounjaro, Trulicity, Zepbound |
| Novo Nordisk INC | $387.62 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $243.38 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.10 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $156.59 | 2019-2023 | Farxiga |
| Dexcom, INC. | $110.15 | 2019-2023 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $100.23 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $91.15 | 2019-2020 | |
| Insulet Corporation | $70.23 | 2019-2023 | Omnipod |
| Becton, Dickinson and Company | $58.83 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $52.52 | 2022-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $47.49 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $44.73 | 2022 | |
| Cequr Corporation | $43.30 | 2023 | Cequr Simplicity |
| Medtronic, INC. | $42.81 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $42.51 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $30.51 | 2022 | |
| Nevro Corp. | $30.11 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $30.00 | 2023 | Imcivree |
| Janssen Pharmaceuticals, INC | $22.62 | 2019 | |
| Lifescan, INC. | $21.77 | 2022 | |
| Aspira Women'S Health INC | $16.69 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Rivera-Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.